JPH107582A - Skin lotion - Google Patents

Skin lotion

Info

Publication number
JPH107582A
JPH107582A JP8181322A JP18132296A JPH107582A JP H107582 A JPH107582 A JP H107582A JP 8181322 A JP8181322 A JP 8181322A JP 18132296 A JP18132296 A JP 18132296A JP H107582 A JPH107582 A JP H107582A
Authority
JP
Japan
Prior art keywords
skin
extract
added
examples
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP8181322A
Other languages
Japanese (ja)
Other versions
JP3805022B2 (en
Inventor
Masumi Takei
増美 竹井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Noevir Co Ltd
Original Assignee
Noevir Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Noevir Co Ltd filed Critical Noevir Co Ltd
Priority to JP18132296A priority Critical patent/JP3805022B2/en
Publication of JPH107582A publication Critical patent/JPH107582A/en
Application granted granted Critical
Publication of JP3805022B2 publication Critical patent/JP3805022B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To provide a skin lotion, having agingpreventing, antiinflammatory and skin lightening effects, antimicrobial actions, exhibiting cleaning actions on skin, excellent in stability and safety. SOLUTION: This skin lotion comprises one or more selected from an extract of Pleione sp., an extract of Cremastra appendiculata Makino, an extract of Pleione bulbocodioides and an extract of Tulipa edulis Baker. These extracts have aging-preventing, anti-inflammatroy and skin lightening effects by the elimination of the source of active oxygen.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、優れた活性酸素種
の消去作用を有し、且つ抗菌活性及び美白作用を合わせ
て発揮することができ、皮膚の老化症状や炎症の防止,
改善、清浄化及び色素沈着症状の防止,改善に有用で、
安定性及び安全性に優れる皮膚外用剤に関する。さらに
詳しくは、生薬「山慈姑」の抽出物、或いはその基原植
物であるサイハイラン(Cremastra appendiculata Maki
no)、ドクサンラン(Pleione bulbocodioides)、又は
アマナ(Tulipa edulis Baker)の各抽出物の1種又は
2種以上を含有して成る皮膚外用剤に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention has an excellent elimination effect of reactive oxygen species, and can exert both antibacterial activity and whitening effect.
Useful for improvement, cleansing, prevention and improvement of pigmentation symptoms,
The present invention relates to an external preparation for skin having excellent stability and safety. More specifically, the extract of the herbal medicine "Yamajugi" or its base plant, Saihyran ( Crematra appendiculata Maki)
The present invention relates to an external preparation for skin comprising one or more extracts of each of the following extracts: no), doxanlan ( Pleione bulbocodioides ), or amana ( Tulipa edulis Baker).

【0002】[0002]

【従来の技術】皮膚は、熱,紫外線,種々の化学物質
等、環境中に存在する種々のストレスにさらされてい
る。その結果、皮膚においては紅斑,浮腫といった炎症
反応や、アレルギー反応、メラニン生成による黒化とい
った反応が生じ、さらに長期間にわたりかかるストレス
にさらされた結果、皮膚のしわやしみの発生,弾力の低
下といった老化症状が進行することが明らかにされてき
ている。また、皮膚上には種々の常在細菌が存在し、そ
れらが皮脂や老廃物を資化して異常に増殖したり、菌叢
が変化することが、尋常性ざ瘡やふけ発生の一因である
ことも知られている。
2. Description of the Related Art Skin is exposed to various stresses existing in the environment, such as heat, ultraviolet rays, and various chemical substances. As a result, inflammatory reactions such as erythema and edema, allergic reactions, and blackening due to melanin production occur on the skin. As a result of being subjected to the stress for a long period of time, wrinkles and wrinkles of the skin occur, and elasticity decreases. It has been revealed that such aging symptoms progress. In addition, various indigenous bacteria are present on the skin, and they assimilate sebum and waste products and abnormally proliferate and change the flora, which is one of the causes of acne vulgaris and dandruff It is also known that there is.

【0003】従って、上記の炎症等を防止し、皮膚の黒
化や老化を防止したり、皮膚の殺菌,清浄化を行うよう
な有効成分の探求が行われ、それらを含有する皮膚外用
剤の提供が試みられてきた。たとえば、抗炎症剤として
はβ-グリチルレチン酸,グリチルリチン酸,それらの
塩及び誘導体、アラントイン及びその誘導体、アズレ
ン,ε-アミノカプロン酸,ハイドロコルチゾン等、ア
レルギー症状の緩和には、塩酸ジフェンヒドラミン,マ
レイン酸クロルフェニラミン等の抗ヒスタミン剤が用い
られ、美白剤としては、アスコルビン酸及びその誘導
体,コウジ酸及びその誘導体,アルブチン等のハイドロ
キノン誘導体等、皮膚の殺菌,清浄化剤としては、ヒノ
キチオール,ジンクピリチオン,感光素等が用いられて
いる。また近年、酸化ストレスによる皮膚の老化がクロ
ーズアップされ、ビタミンEやスーパーオキシドディス
ムターゼ等、活性酸素種の消去剤の配合も行われてい
る。
[0003] Accordingly, the search for effective ingredients for preventing the above-mentioned inflammation and the like, for preventing the skin from being blackened or aged, and for sterilizing and cleaning the skin has been conducted. Offering has been attempted. For example, anti-inflammatory agents include β-glycyrrhetinic acid, glycyrrhizic acid, salts and derivatives thereof, allantoin and its derivatives, azulene, ε-aminocaproic acid, hydrocortisone, and the like. For alleviation of allergic symptoms, diphenhydramine hydrochloride, chlore maleate. Antihistamines such as pheniramine are used. As whitening agents, ascorbic acid and its derivatives, kojic acid and its derivatives, hydroquinone derivatives such as arbutin, etc., and as bactericidal and cleansing agents for skin, hinokitiol, zinc pyrithione, photosensitizer, etc. Is used. In recent years, aging of skin due to oxidative stress has been highlighted, and elimination agents for active oxygen species such as vitamin E and superoxide dismutase have been added.

【0004】しかしながら、従来用いられていた上記の
成分には、光や熱等に対して不安定なものが多く、また
作用,効果が不十分で、外用剤基剤に配合して十分な効
果を得るには、かなりの多量を配合する必要があった。
さらに、皮膚の老化防止,美白及び皮膚の殺菌,清浄化
と、すべての効果を合わせて発揮し得る成分は少なく、
これらの効果をまんべんなく発揮させるには、多種類の
成分を併用する必要があり、併用する成分によっては、
それぞれの安定性及び作用の低減を来すこともあった。
[0004] However, many of the above-mentioned components which have been conventionally used are unstable to light and heat, etc., and their actions and effects are insufficient. In order to obtain, it was necessary to blend a considerably large amount.
Furthermore, there are few ingredients that can exhibit all effects together with anti-aging of skin, whitening and sterilization and cleansing of skin,
In order to exert these effects evenly, it is necessary to use various types of components in combination, and depending on the components used in combination,
The respective stability and action may be reduced.

【0005】[0005]

【発明が解決しようとする課題】本発明は上記のような
問題点の解消を図り、少量,少種類の有効成分を含有す
るのみで、老化防止,美白及び皮膚の殺菌,清浄化の各
効果を合わせ持ち、且つ安定性及び安全性に優れる皮膚
外用剤を提供することを目的とする。
DISCLOSURE OF THE INVENTION The present invention aims to solve the above-mentioned problems, and contains only a small amount and a small number of active ingredients, and has the effects of preventing aging, whitening and disinfecting and purifying the skin. An object of the present invention is to provide an external preparation for skin having excellent stability and safety.

【0006】[0006]

【課題を解決するための手段】上記の課題を解決するた
め種々検討したところ、生薬として用いられる山慈姑の
抽出物や、その基原植物であるサイハイラン(Cremastr
a appendiculata Makino)、ドクサンラン(Pleione bu
lbocodioides)、及びアマナ(Tulipa edulisBaker)の
各抽出物に強い老化防止効果,美白効果及び抗菌作用が
あり、さらにこれらを皮膚外用剤基剤に添加したとき、
前記作用,効果が基剤成分の影響を受けることなく、ま
た保存安定性にも優れることを見い出し、本発明を完成
するに至った。
Various studies have been made to solve the above-mentioned problems. As a result, an extract of Yamajugi used as a crude drug, and its base plant, Cyhailan ( Cremastr.)
a appendiculata Makino), Doxanlan ( Pleione bu )
lbocodioides ) and Amana ( Tulipa edulis Baker) extracts have strong anti-aging, whitening and antibacterial effects, and when these are added to the skin external preparation base,
The present inventors have found that the above-mentioned actions and effects are not affected by the base component and are excellent in storage stability, and have completed the present invention.

【0007】従って本発明においては、生薬である山慈
姑の抽出物、又はサイハイラン(Cremastra appendicul
ata Makino)の抽出物、ドクサンラン(Pleione bulboc
odioides)の抽出物、及びアマナ(Tulipa edulis Bake
r)の抽出物より選ばれる1種又は2種以上を皮膚外用
剤基剤に含有させる。
[0007] Therefore, in the present invention, a crude drug, an extract of San Ji-Gu, or Saihyran ( Cremastra appendicul)
ata Makino extract, Pleione bulboc
odioides ) and Amana ( Tulipa edulis Bake)
One or more selected from the extracts of r) are contained in the base for external preparation for skin.

【0008】抽出溶媒としては、水の他、メタノール,
エタノール,プロパノール,イソプロパノール,1,3-ブ
チレングリコール,プロピレングリコール等のアルコー
ル類、酢酸エチル,アセトン等の極性の高い有機溶媒よ
り1種又は2種以上を用いることができる。
[0008] As an extraction solvent, in addition to water, methanol,
One or more of alcohols such as ethanol, propanol, isopropanol, 1,3-butylene glycol, and propylene glycol, and highly polar organic solvents such as ethyl acetate and acetone can be used.

【0009】抽出に供する生薬の山慈姑は、サイハイラ
ンの球茎又はドクサンランの仮鱗茎、或いはアマナの鱗
茎を乾燥したものである。これらの他に、サイハイラ
ン,ドクサンラン及びアマナの花,茎,葉等の部位、又
は全草をも抽出に用いることができる。抽出は生植物の
まま行ってもよく、細切或いは乾燥,粉砕等の処理を行
った後に行ってもよい。
The herbal medicine Yamajigi used for the extraction is obtained by drying the bulb of Saihailan or the temporary bulb of Doxanlan or the bulb of Amana. In addition to these, sites such as flowers, stems, leaves, and the like, and the whole plant can be used for extraction. The extraction may be carried out as it is on a live plant, or may be carried out after processing such as shredding, drying and pulverization.

【0010】また、抽出物はそのままでも外用剤基剤に
添加できるが、水,アルコール等の溶媒で希釈したり、
濃縮,乾固したものをアルコール等の極性溶媒に再度溶
解したり、或いは脱色,脱臭等の処理を行った後に添加
してもよい。皮膚外用剤への配合量としては、山慈姑或
いはその基原植物を十分浸漬し得る量の溶媒にて抽出し
て得た粗抽出物の状態で、0.001〜10.0重量%
程度とするのが好ましい。
The extract can be added to the external preparation base as it is, but it can be diluted with a solvent such as water or alcohol,
The concentrated or dried product may be dissolved again in a polar solvent such as alcohol, or may be added after performing a treatment such as decolorization and deodorization. As a compounding amount in the external preparation for skin, a crude extract obtained by extracting with a solvent of an amount capable of sufficiently immersing Yamajigi or its base plant, in a state of 0.001 to 10.0% by weight
It is preferable to set the degree.

【0011】なお本発明においては、山慈姑等の抽出物
に加えて、他の活性酸素種消去剤や抗炎症剤、美白剤、
殺菌剤の他、油類,保湿剤,紫外線吸収剤,香料,防腐
剤等、一般的な外用剤及び化粧料用原料をも含有させる
ことができる。
[0011] In the present invention, in addition to the extract of Yamajiku and others, other active oxygen species scavengers, anti-inflammatory agents, whitening agents,
In addition to bactericides, general external preparations such as oils, humectants, ultraviolet absorbers, fragrances, and preservatives and raw materials for cosmetics can be contained.

【0012】[0012]

【作用】本発明による皮膚外用剤は、優れた活性酸素種
消去作用及び抗炎症作用等に基づく皮膚の老化防止作
用、チロシナーゼ阻害作用等に基づく美白作用、及び殺
菌,抗菌作用を合わせ持つ。
The external preparation for skin according to the present invention has an excellent antioxidant action of the skin based on an excellent elimination action of active oxygen species and an anti-inflammatory action, a whitening action based on a tyrosinase inhibitory action, and a bactericidal and antibacterial action.

【0013】従って、本発明に係る皮膚外用剤は、主に
酸化的ストレスに起因する皮膚の老化症状の改善及び防
止、肌荒れ等の皮膚における炎症の治療及び防止、し
み,そばかすをはじめ太田母斑等の色素沈着症や日焼け
による黒化の改善及び防止、及び尋常性ざ瘡,ふけ症等
の皮膚常在菌の異常に起因する症状の緩和及び防止にお
いて、優れた作用,効果を示す。
Therefore, the external preparation for skin according to the present invention can improve and prevent aging symptoms of the skin mainly caused by oxidative stress, treat and prevent inflammation in the skin such as rough skin, spots, freckles, etc. It has an excellent action and effect in the improvement and prevention of pigmentation and blackening due to sunburn, etc., and in the mitigation and prevention of symptoms caused by abnormalities of indigenous skin bacteria such as acne vulgaris and dandruff.

【0014】加えて、優れた殺菌,抗菌作用により、細
菌,真菌等の微生物による汚染を良好に防ぐことがで
き、製剤の安定性を向上させることができる。
In addition, due to excellent sterilization and antibacterial effects, contamination by microorganisms such as bacteria and fungi can be prevented well, and the stability of the preparation can be improved.

【0015】[0015]

【発明の実施の形態】本発明は、ローション剤,乳剤,
ゲル剤,クリーム,軟膏等の剤型の皮膚外用剤として提
供することができる。また、化粧水,乳液,クリーム等
の皮膚用化粧料、メイクアップベースローション,メイ
クアップベースクリーム,液状又はクリーム状或いは軟
膏型のファンデーション,アイカラー,チークカラーと
いったメイクアップ化粧料、シャンプー,リンス,ヘア
ートリートメント等の毛髪用化粧料、ハンドクリーム,
レッグクリーム,ボディローション等の身体用化粧料な
どとしても提供され得る。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a lotion, an emulsion,
It can be provided as a skin external preparation in the form of a gel, cream, ointment or the like. Also, skin cosmetics such as lotions, emulsions and creams, makeup base lotions, makeup base creams, liquid or creamy or ointment type foundations, makeup cosmetics such as eye color and teak color, shampoo, rinse, Hair cosmetics such as hair treatments, hand creams,
They can also be provided as body cosmetics such as leg creams and body lotions.

【0016】[0016]

【実施例】さらに本発明について、実施例により詳細に
説明する。
EXAMPLES The present invention will be described in more detail with reference to Examples.

【0017】 [実施例1] 皮膚用ローション剤 (1)エタノール 10.0(重量%) (2)ヒドロキシエチルセルロース 1.0 (3)サイハイラン全草のエタノール抽出物 5.0 (4)精製水 84.0 製法:(1)〜(4)を混合し均一とする。[Example 1] Lotion for skin (1) Ethanol 10.0 (wt%) (2) Hydroxyethylcellulose 1.0 (3) Ethanol extract of whole plant of Saihailan 5.0 (4) Purified water 84 0.0 Production method: (1) to (4) are mixed and made uniform.

【0018】 [実施例2] 皮膚用乳剤 (1)ステアリン酸 0.2(重量%) (2)セタノール 1.5 (3)ワセリン 3.0 (4)流動パラフィン 7.0 (5)ポリオキシエチレン(10E.O.)モノオレイン酸 1.5 エステル (6)酢酸トコフェロール 5.0 (7)グリセリン 5.0 (8)パラオキシ安息香酸メチル 0.1 (9)トリエタノールアミン 1.0 (10)精製水 71.7 (11)サイハイラン全草のメタノール抽出物 2.0 (12)ドクサンラン全草の酢酸エチル抽出物 2.0 製法:(1)〜(6)の油相成分を混合,加熱して均一に溶解
し、70℃に保つ。一方、(7)〜(10)の水相成分を混
合,加熱して均一とし、70℃とする。この水相成分に
前記油相成分を攪拌しながら徐々に添加して乳化し、冷
却した後40℃にて(11),(12)を添加する。
Example 2 Emulsion for skin (1) Stearic acid 0.2 (% by weight) (2) Cetanol 1.5 (3) Vaseline 3.0 (4) Liquid paraffin 7.0 (5) Polyoxy Ethylene (10E.O.) monooleic acid 1.5 ester (6) Tocopherol acetate 5.0 (7) Glycerin 5.0 (8) Methyl parahydroxybenzoate 0.1 (9) Triethanolamine 1.0 (10 ) Purified water 71.7 (11) Methanol extract of whole plant of Saihailan 2.0 (12) Ethyl acetate extract of whole plant of doxanlan 2.0 Manufacturing method: Mix and heat oil phase components (1) to (6) Dissolve uniformly and keep at 70 ° C. On the other hand, the aqueous phase components (7) to (10) are mixed and heated to be uniform, and the temperature is set to 70 ° C. The oil phase component is gradually added to the aqueous phase component while stirring to emulsify, and after cooling, (11) and (12) are added at 40 ° C.

【0019】 [実施例3] 皮膚用ゲル剤 (1)ジプロピレングリコール 10.0(重量%) (2)カルボキシビニルポリマー 0.5 (3)水酸化カリウム 0.1 (4)パラオキシ安息香酸メチル 0.1 (5)精製水 84.3 (6)アスコルビン酸リン酸エステルマグネシウム塩 4.0 (7)山慈姑酢酸エチル抽出物のエタノール溶液 1.0 製法:(5)に(2)を均一に溶解させた後、(1)に(4)を溶解
させて添加し、次いで(3)を加えて増粘させ、(6),(7)
を添加する。
Example 3 Skin Gel (1) Dipropylene glycol 10.0 (% by weight) (2) Carboxyvinyl polymer 0.5 (3) Potassium hydroxide 0.1 (4) Methyl paraoxybenzoate 0.1 (5) Purified water 84.3 (6) Ascorbic acid phosphoric acid ester magnesium salt 4.0 (7) Ethanol solution of ethyl acetate extract from Yamajiki 1.0 Production method: (5) is homogeneous with (2) After dissolving in (1), (4) is dissolved and added to (1), and then (3) is added to thicken, and (6), (7)
Is added.

【0020】 [実施例4] 皮膚用クリーム (1)ミツロウ 6.0(重量%) (2)セタノール 5.0 (3)還元ラノリン 8.0 (4)スクワラン 27.5 (5)グリセリル脂肪酸エステル 4.0 (6)親油型グリセリルモノステアリン酸エステル 2.0 (7)ポリオキシエチレン(20E.O.)ソルビタン 5.0 モノラウリン酸エステル (8)プロピレングリコール 5.0 (9)パラオキシ安息香酸メチル 0.1 (10)精製水 30.4 (11)レチノールパルミチン酸エステル 1.0 (12)サイハイラン全草の50重量%プロピレン 3.0 グリコール抽出物 (13)アマナ全草の50重量%1,3-ブチレングリコール 3.0 抽出物 製法:(1)〜(7)の油相成分を混合,溶解して75℃に加
熱する。一方、(8)〜(10)の水相成分を混合,溶解して
75℃に加熱する。次いで、上記水相成分に油相成分を
添加して予備乳化した後、ホモミキサーにて均一に乳化
し、冷却後40℃にて(11)〜(13)を添加する。
Example 4 Skin Cream (1) Beeswax 6.0 (% by weight) (2) Cetanol 5.0 (3) Reduced Lanolin 8.0 (4) Squalane 27.5 (5) Glyceryl fatty acid ester 4.0 (6) Lipophilic glyceryl monostearate 2.0 (7) Polyoxyethylene (20E.O.) sorbitan 5.0 Monolaurate (8) Propylene glycol 5.0 (9) Paraoxybenzoic acid Methyl 0.1 (10) Purified water 30.4 (11) Retinol palmitate 1.0 (12) 50% by weight of Saihyran whole plant Propylene 3.0 Glycol extract (13) 50% by weight of Amana whole plant , 3-butylene glycol 3.0 extract Production method: Mix and dissolve the oil phase components (1) to (7) and heat to 75 ° C. On the other hand, the aqueous phase components (8) to (10) are mixed and dissolved, and heated to 75 ° C. Next, the oil phase component is added to the water phase component and pre-emulsified, and then uniformly emulsified by a homomixer. After cooling, (11) to (13) are added at 40 ° C.

【0021】 [実施例5] 水中油型乳剤性軟膏 (1)白色ワセリン 25.0(重量%) (2)ステアリルアルコール 25.0 (3)グリセリン 12.0 (4)ラウリル硫酸ナトリウム 1.0 (5)パラオキシ安息香酸メチル 0.1 (6)精製水 33.9 (7)レチノイン酸 0.5 (8)サイハイラン全草の50重量%プロパノール 1.5 抽出物 (9)ドクサンラン全草の60重量%エタノール抽出物 0.5 (10)アマナ全草の60重量%エタノール抽出物 0.5 製法:(1)〜(4)の油相成分を混合,溶解して均一とし、
75℃に加熱する。一方、(5)及び(6)の水相成分を混
合,溶解して75℃に加熱し、これに前記油相成分を添
加して乳化し、冷却後40℃にて(7)〜(10)を添加,混
合する。
Example 5 Oil-in-water emulsion ointment (1) White petrolatum 25.0 (% by weight) (2) Stearyl alcohol 25.0 (3) Glycerin 12.0 (4) Sodium lauryl sulfate 1.0 (5) Methyl paraoxybenzoate 0.1 (6) Purified water 33.9 (7) Retinoic acid 0.5 (8) 50% by weight propanol 1.5 extract of Saihyran whole plant (9) 60 of Doxanlan whole plant 0.5% by weight ethanol extract 0.5 (10) 60% by weight ethanol extract of amana whole plant 0.5 Production method: Mix and dissolve the oil phase components of (1) to (4) to make uniform,
Heat to 75 ° C. On the other hand, the aqueous phase components (5) and (6) were mixed and dissolved, heated to 75 ° C., added with the oil phase component and emulsified, cooled, and then cooled to 40 ° C. at (7) to (10). ) Is added and mixed.

【0022】 [実施例6] 化粧水 (1)エタノール 10.0(重量%) (2)1,3-ブチレングリコール 5.0 (3)サイハイラン花のエタノール抽出物 0.5 (4)香料 0.1 (5)精製水 84.4 製法:(1)〜(4)を順次(5)に添加して均一に混合,溶解
する。
Example 6 Lotion (1) Ethanol 10.0 (% by weight) (2) 1,3-butylene glycol 5.0 (3) Ethanol extract of Saihailan flower 0.5 (4) Fragrance 0 1.1 (5) Purified water 84.4 Production method: (1) to (4) are sequentially added to (5) and uniformly mixed and dissolved.

【0023】 [実施例7] エモリエントクリーム(油中水型) (1)流動パラフィン 30.0(重量%) (2)マイクロクリスタリンワックス 2.0 (3)ワセリン 5.0 (4)ジグリセリルジオレイン酸エステル 5.0 (5)L-グルタミン酸ナトリウム 1.6 (6)L-セリン 0.4 (7)プロピレングリコール 3.0 (8)パラオキシ安息香酸メチル 0.1 (9)精製水 52.4 (10)ドクサンラン茎,葉の50重量%プロピレン 0.2 グリコール抽出物 (11)アマナ茎,葉,花の1,3-ブチレングリコール 0.2 抽出物 (12)香料
0.1製法:(5),(6)を(9)の一部に溶解して50℃と
し、50℃に加熱した(4)に攪拌しながら徐々に添加す
る。これをあらかじめ混合し70℃に加熱溶解した(1)
〜(3)に均一に分散し、これに(7),(8)を(9)の残部に溶
解して70℃に加熱したものを攪拌しながら添加し、ホ
モミキサーにて乳化する。冷却後、40℃にて(10)〜(1
2)を添加,混合する。
[Example 7] Emollient cream (water-in-oil type) (1) Liquid paraffin 30.0 (% by weight) (2) Microcrystalline wax 2.0 (3) Vaseline 5.0 (4) Diglyceryl geo Leic acid ester 5.0 (5) Sodium L-glutamate 1.6 (6) L-serine 0.4 (7) Propylene glycol 3.0 (8) Methyl parahydroxybenzoate 0.1 (9) Purified water 52. 4 (10) 50% by weight propylene 0.2 glycol extract of doxanlan stem and leaf (11) 1,3-butylene glycol 0.2 extract of amana stem, leaf and flower (12) Fragrance
0.1 Production method: (5) and (6) are dissolved in a part of (9) to 50 ° C., and gradually added to (4) heated to 50 ° C. with stirring. This was previously mixed and dissolved by heating to 70 ° C. (1)
(7) and (8) are dissolved in the remainder of (9), heated to 70 ° C., added with stirring, and emulsified by a homomixer. After cooling, at 40 ° C (10)-(1
2) Add and mix.

【0024】 [実施例8] メイクアップベースクリーム (1)ステアリン酸 12.00(重量%) (2)セタノール 2.00 (3)グリセリルトリ2-エチルヘキサン酸エステル 2.50 (4)自己乳化型グリセリルモノステアリン酸エステル 2.00 (5)プロピレングリコール 10.00 (6)水酸化カリウム 0.30 (7)パラオキシ安息香酸メチル 0.10 (8)精製水 69.49 (9)二酸化チタン 1.00 (10)ベンガラ 0.10 (11)黄酸化鉄 0.40 (12)香料 0.10 (13)山慈姑のエタノール抽出物 0.01 製法:(1)〜(4)の油相成分を混合し、75℃に加熱して
均一とする。一方(5)〜(8)の水相成分を混合し、75℃
に加熱,溶解して均一とし、これに(9)〜(11)の顔料を
添加し、ホモミキサーにて均一に分散させる。この水相
成分に前記油相成分を添加し、ホモミキサーにて乳化し
た後冷却し、40℃にて(12),(13)を添加,混合する。
Example 8 Makeup Base Cream (1) Stearic acid 12.00 (% by weight) (2) Cetanol 2.00 (3) Glyceryl tri-2-ethylhexanoate 2.50 (4) Self-emulsification Type glyceryl monostearate 2.00 (5) Propylene glycol 10.00 (6) Potassium hydroxide 0.30 (7) Methyl paraoxybenzoate 0.10 (8) Purified water 69.49 (9) Titanium dioxide 1 .00 (10) Bengala 0.10 (11) Yellow iron oxide 0.40 (12) Fragrance 0.10 (13) Ethanol extract of Yamajiku 0.01 Production method: Oil phase components of (1) to (4) And heat to 75 ° C. to make uniform. On the other hand, mix the aqueous phase components (5) to (8)
The mixture is heated and dissolved to make the mixture uniform, and the pigments (9) to (11) are added to the mixture and uniformly dispersed by a homomixer. The oil phase component is added to the water phase component, emulsified by a homomixer, cooled, and (12) and (13) are added and mixed at 40 ° C.

【0025】 [実施例9] 液状ファンデーション (1)ステアリン酸 2.00(重量%) (2)スクワラン 5.00 (3)ミリスチン酸オクチルドデシル 5.00 (4)セタノール 1.00 (5)ポリグリセリルモノイソパルミチン酸エステル 9.00 (6)1,3-ブチレングリコール 6.00 (7)水酸化カリウム 0.10 (8)パラオキシ安息香酸メチル 0.10 (9)精製水 53.35 (10)酸化チタン 9.00 (11)タルク 7.40 (12)ベンガラ 0.50 (13)黄酸化鉄 1.10 (14)黒酸化鉄 0.10 (15)香料 0.15 (16)山慈姑の1,3-ブチレングリコール抽出物 0.20 製法:(1)〜(5)の油相成分を混合し、75℃に加熱して
均一とする。一方(6)〜(9)の水相成分を混合し、75℃
に加熱,溶解して均一とし、これに(10)〜(14)の顔料を
添加し、ホモミキサーにて均一に分散させる。この水相
成分に前記油相成分を添加し、ホモミキサーにて乳化し
た後冷却し、40℃にて(15),(16)を添加,混合する。
Example 9 Liquid Foundation (1) Stearic acid 2.00 (% by weight) (2) Squalane 5.00 (3) Octyldodecyl myristate 5.00 (4) Cetanol 1.00 (5) Polyglyceryl Monoisopalmitate 9.00 (6) 1,3-butylene glycol 6.00 (7) Potassium hydroxide 0.10 (8) Methyl parahydroxybenzoate 0.10 (9) Purified water 53.35 (10) Titanium oxide 9.00 (11) Talc 7.40 (12) Bengala 0.50 (13) Yellow iron oxide 1.10 (14) Black iron oxide 0.10 (15) Fragrance 0.15 (16) 1,3-butylene glycol extract 0.20 Production method: Mix the oil phase components (1) to (5) and heat to 75 ° C. to make uniform. On the other hand, the aqueous phase components of (6) to (9) were mixed and
The mixture is heated and dissolved to make the mixture uniform, and the pigments (10) to (14) are added to the mixture and uniformly dispersed by a homomixer. The oil phase component is added to the aqueous phase component, emulsified by a homomixer, cooled, and (15) and (16) are added and mixed at 40 ° C.

【0026】 [実施例10] シャンプー (1)アルキルエーテル硫酸ナトリウム 18.000(重量%) (2)ヤシ油脂肪酸ジエタノールアミド 2.000 (3)プロピレングリコール 2.000 (4)サイハイラン全草のエタノール抽出物 2.000 (5)黄色4号 0.001 (6)香料 0.200 (7)精製水 75.799 製法:(1)〜(6)を順次(7)に添加して均一とする。Example 10 Shampoo (1) Sodium alkyl ether sulfate 18.000 (% by weight) (2) Coconut oil fatty acid diethanolamide 2.000 (3) Propylene glycol 2.000 (4) Ethanol of whole plant of Saihyran Extract 2.000 (5) Yellow No. 4 0.001 (6) Fragrance 0.200 (7) Purified water 75.799 Production method: (1) to (6) are sequentially added to (7) to make it uniform .

【0027】 [実施例11] ヘアーリンス (1)セタノール 3.000(重量%) (2)塩化ステアリルトリメチルアンモニウム 0.700 (3)グリセリン 3.000 (4)N-ココイル-L-アルギニンエチルエステル 0.100 -DL-ピロリドンカルボン酸塩 (5)緑色3号 0.002 (6)精製水 90.098 (7)香料 0.100 (8)ドクサンラン全草のグリセリン抽出物 1.500 (9)アマナ全草のグリセリン抽出物 1.500 製法:(3)〜(6)の水相成分を混合,溶解し、70℃に加
熱する。一方、(1),(2)の油相成分を混合,溶解し、7
0℃に加熱する。この油相を攪拌しながら前記水相に徐
々に添加して予備乳化し、ホモミキサーにより均一とし
た後冷却し、40℃にて(7)〜(9)を添加,混合する。
Example 11 Hair rinse (1) Cetanol 3.000 (% by weight) (2) Stearyltrimethylammonium chloride 0.700 (3) Glycerin 3.000 (4) N-cocoyl-L-arginine ethyl ester 0.100 -DL-pyrrolidonecarboxylate (5) Green No. 3 0.002 (6) Purified water 90.098 (7) Fragrance 0.100 (8) Glycerin extract of whole doxanlan 1.500 (9) Glycerin extract of Amana whole plant 1.500 Production method: Mix and dissolve the aqueous phase components (3) to (6) and heat to 70 ° C. On the other hand, the oil phase components (1) and (2) were mixed and dissolved,
Heat to 0 ° C. The oil phase is gradually added to the aqueous phase while stirring, pre-emulsified, homogenized by a homomixer, cooled, and (7) to (9) are added and mixed at 40 ° C.

【0028】 [実施例12] 液体ボディ洗浄料 (1)N-ラウロイル-L-グルタミン酸トリエタノール 20.0(重量%) アミン(30.0重量%水溶液) (2)N-ラウリルメチルタウリンナトリウム 10.0 (30.0重量%水溶液) (3)ラウリン酸トリエタノールアミン 10.0 (4)ミリスチン酸トリエタノールアミン 10.0 (5)ラウリルイミダゾリニウムベタイン 5.0 (6)ラウロイルジエタノールアミド 5.0 (7)プロピレングリコール 7.0 (8)精製水 28.4 (9)香料 0.1 (10)サイハイラン全草のエタノール抽出物 1.5 (11)ドクサンラン全草のエタノール抽出物 1.5 (12)アマナ全草のエタノール抽出物 1.5 製法:(1)〜(12)の各成分を順次添加混合して均一とす
る。
Example 12 Liquid Body Cleanser (1) N-Lauroyl-L-Glutamate Triethanol 20.0 (% by weight) Amine (30.0% by weight aqueous solution) (2) N-Laurylmethyltaurine Sodium 10 0.0 (30.0% by weight aqueous solution) (3) Triethanolamine laurate 10.0 (4) Triethanolamine myristate 10.0 (5) Lauryl imidazolinium betaine 5.0 (6) Lauroyl diethanolamide 5 0.0 (7) Propylene glycol 7.0 (8) Purified water 28.4 (9) Fragrance 0.1 (10) Ethanol extract of whole plant of Saihyran 1.5 (11) Ethanol extract of whole plant of doxanlan 1. 5 (12) Ethanol extract of Amana whole plant 1.5 Production method: The components of (1) to (12) are sequentially added and mixed to make uniform.

【0029】上記実施例のうち、実施例1〜実施例5に
ついて、老化防止効果,肌荒れ改善効果及び美白効果を
評価した。その際、各実施例において、サイハイラン,
ドクサンラン及びアマナの全草抽出物を各抽出溶媒に、
また山慈姑の酢酸エチル抽出物のエタノール溶液をエタ
ノールに代替して比較例1〜比較例5とし、同様に評価
を行った。
Of the above Examples, Examples 1 to 5 were evaluated for their anti-aging effect, skin roughness improvement effect, and whitening effect. At that time, in each example,
Doxanlan and Amana whole plant extract in each extraction solvent,
In addition, Comparative Example 1 to Comparative Example 5 were performed by replacing ethanol solution of the ethyl acetate extract of Yamagigi with ethanol, and evaluation was performed in the same manner.

【0030】まず、皮膚の老化防止効果は、ヘアレスマ
ウスにおけるしわの発生に対する効果の評価により行っ
た。前記評価は、ヘアレスマウス5匹を1群とし、各群
について実施例及び比較例をそれぞれ1日1回背部に塗
布し、1J/cm2/週の長波長紫外線(UVA)を50
週間照射し、ヘアレスマウス背部皮膚におけるしわの発
生状況を観察し、表1に示す判定基準に従って点数化し
て行った。この際、精製水のみを塗布した群を対照とし
た。結果は、各群の平均値を算出し、UVA照射日数と
の関係により表2に示した。
First, the effect of preventing skin aging was evaluated by evaluating the effect on wrinkling in hairless mice. In the evaluation, five hairless mice were divided into one group, and the examples and the comparative examples were applied to the back once a day for each group, and 50 JL / cm 2 / week long-wave ultraviolet light (UVA) was applied.
Irradiation was performed for a week, the occurrence of wrinkles on the back skin of the hairless mouse was observed, and scored according to the criteria shown in Table 1. At this time, a group to which only purified water was applied was used as a control. The results are shown in Table 2 by calculating the average value of each group and showing the relationship with the number of UVA irradiation days.

【表1】 [Table 1]

【0031】次に肌荒れに対する改善効果は、顕著な肌
荒れ症状を有する女性パネラー20名を1群とし、各群
に実施例及び比較例のそれぞれを1日2回、ブラインド
にて1カ月間連続使用させ、1カ月後の皮膚の症状を観
察して、使用開始前と比較して行った。皮膚の肌荒れ症
状は表3に示す判定基準に従って点数化し、20名の平
均値を算出し、表4に示した。
Next, the effect of improving skin roughness was evaluated by using 20 female panelists with remarkable skin roughness symptoms as a group, and using the examples and comparative examples twice a day in each group continuously for one month in a blind. After one month, the symptoms of the skin were observed and compared with before the start of use. The skin roughness symptoms were scored according to the criteria shown in Table 3 and the average value of 20 persons was calculated.

【表3】 [Table 3]

【0032】続いて色素沈着症状の改善効果は、顕著な
シミ,ソバカス等の色素沈着症状を有する女性パネラー
20名を1群とし、各群に実施例及び比較例をそれぞれ
ブラインドにて1日2回ずつ1カ月間使用させ、1カ月
後の皮膚の色素沈着の状態を観察して使用前と比較して
行った。色素沈着の状況は表5に示す判定基準に従って
評価し、20名の平均値を算出し、表4にまとめて示し
た。
Subsequently, the effect of improving the pigmentation symptom was evaluated by assuming that 20 female panelists having remarkable pigmentation symptoms such as spots and freckles were grouped into one group, and the examples and comparative examples were blinded to each group for 2 days a day. It was used for one month each time, and the state of pigmentation of the skin after one month was observed and compared with that before use. The state of pigmentation was evaluated according to the criteria shown in Table 5, and the average value of 20 persons was calculated. The results are shown in Table 4.

【表5】 [Table 5]

【0033】[0033]

【表2】 表2において、対照群では50週後にはほとんどのヘア
レスマウスに深いしわの発生が認められているが、本発
明の実施例塗布群では、いずれにおいてもしわの発生は
顕著に抑制されており、50週後に微小なしわ又は軽微
なしわの発生を認めたのみであった。特に、山慈姑の抽
出物の溶液を添加した実施例3塗布群では、良好なしわ
防止効果が認められていた。これに対し、比較例1塗布
群ではほとんどしわの発生の抑制は認められておらず、
老化防止効果を有するビタミン類である酢酸トコフェロ
ール等を含有する比較例2〜比較例5塗布群において
も、十分なしわの発生抑制は認められていなかった。
[Table 2] In Table 2, occurrence of deep wrinkles was observed in most of the hairless mice in the control group after 50 weeks. However, in the group to which the examples of the present invention were applied, the occurrence of wrinkles was significantly suppressed in all cases. After 50 weeks, only slight wrinkles or slight wrinkles were observed. In particular, in the group applied with Example 3 to which a solution of the extract of Yamajugi was added, a good wrinkle preventing effect was recognized. On the other hand, in Comparative Example 1 application group, almost no suppression of wrinkles was observed,
Also in Comparative Examples 2 to 5 containing the tocopherol acetate, which is a vitamin having an antiaging effect, no sufficient suppression of wrinkles was observed.

【0034】[0034]

【表4】 次に表4より、本発明の実施例使用群においてはいずれ
も良好な肌荒れ症状の改善が認められ、ほぼ良好な皮膚
状態にまで回復していることが示されている。これに対
し、比較例1使用群では肌荒れの改善はあまり認められ
ておらず、比較例2〜比較例5使用群でも、皮膚状態の
回復は不十分であった。
[Table 4] Next, Table 4 shows that in the group using the examples of the present invention, favorable improvement of the rough skin symptom was observed in all the groups, and it was shown that the skin condition was recovered to almost satisfactory. On the other hand, in the group using Comparative Example 1, improvement in skin roughness was not so much recognized, and in the groups using Comparative Example 2 to Comparative Example 5, the recovery of the skin condition was insufficient.

【0035】また色素沈着症状についても、実施例使用
群では良好な改善が認められ、使用試験終了時には、ほ
とんどのパネラーでわずかな色素沈着が見られる程度で
あった。一方比較例使用群では、比較例1及び比較例2
使用群においてはほとんど改善が認められておらず、比
較例3〜比較例5使用群においては、使用試験終了時に
依然として中程度の色素沈着の認められるパネラーが多
く見られた。
In addition, the pigmentation symptom was also favorably improved in the group using the example, and at the end of the use test, slight pigmentation was observed in most of the panelists. On the other hand, in the comparative group, the comparative examples 1 and 2
Almost no improvement was observed in the use group, and in the use groups of Comparative Examples 3 to 5, many panelists still observed moderate pigmentation at the end of the use test.

【0036】続いて実施例6〜実施例12については、
抗菌活性及び保存安定性の評価を行った。なお、各実施
例において、山慈姑等の抽出物を各抽出溶媒に代替した
ものをそれぞれ比較例とし、同時に評価を行った。
Subsequently, in Examples 6 to 12,
Antibacterial activity and storage stability were evaluated. In each of the examples, the extract obtained by substituting an extract such as Jin-Yu for each extraction solvent was used as a comparative example, and was evaluated at the same time.

【0037】抗菌活性は、試験菌として大腸菌(Escher
ichia coli),黄色ブドウ状球菌( Staphylococcus aur
eus),緑膿菌(Pseudomonas aeruginosa),アクネ菌
Propyonibacterium acnes),黒カビ(Aspergillus n
iger )及びふけ菌(Pityrosporum ovale )を用い、これ
らをそれぞれ各実施例及び各比較例に106個/g植菌
し、細菌類は37℃、真菌類は25℃で培養し、2週間
後の生菌数を計測して評価した。結果は、2週間後の生
菌数が細菌については0個、真菌については103個/
g以下となっている場合を合格として、表6に示した。
The antibacterial activity was measured using Escherichia coli (Escher
ichia coli), Staphylococcus aureus ( Staphylococcus aur
eus), Pseudomonas aeruginosa (Pseudomonas aeruginosa) 、 Acne fungus
(Propyonibacterium acnes), Black mold (Aspergillus n
iger ) And dandruff (Pityrosporum ovale )
These were used for each Example and Comparative Example, respectively.6Pcs / g inoculation
Bacteria at 37 ° C and fungi at 25 ° C for 2 weeks
The number of viable bacteria was counted and evaluated. The result is two weeks later
The number of bacteria is 0 for bacteria and 10 for fungiThreePieces/
Table 6 shows the case where the value was equal to or less than g.

【0038】保存安定性は、実施例及び比較例のそれぞ
れを25℃で3カ月間保存し、変色,変臭,相分離や含
有成分の析出といった外観の変化や変質の有無を観察し
て評価した。評価は「○;良好」,「△;やや悪い」,
「×;悪い」として表し、表6にまとめて示した。
The storage stability was evaluated by storing each of the Examples and Comparative Examples at 25 ° C. for 3 months, and observing changes in appearance and deterioration such as discoloration, odor, phase separation and precipitation of contained components. did. Evaluation is "○;good","△; slightly bad",
The results are shown as "x;bad" and are summarized in Table 6.

【0039】[0039]

【表6】 本発明の実施例6〜実施例12は、防腐剤を全く含有し
ないか、或いは低濃度含有するのみであるが、表6にお
いて、いずれについても良好な抗菌活性と保存安定性が
認められている。特に、表中には示していないが、毛髪
用組成物である実施例10及び実施例11では、ふけ菌
が2週間後にすべて死滅しており、抗ふけ効果の高いこ
とが予測された。これに対し、比較例では特に緑膿菌,
黒カビ及びふけ菌に対する抗菌活性が低く、保存安定性
も良くなかった。
[Table 6] Examples 6 to 12 of the present invention do not contain any preservative or contain only a low concentration, but in Table 6, good antibacterial activity and storage stability were observed for all. . In particular, although not shown in the table, in Examples 10 and 11, which are hair compositions, all the dandruff bacteria were killed after 2 weeks, and it was predicted that the antidandruff effect was high. In contrast, in the comparative examples, Pseudomonas aeruginosa
Antibacterial activity against black mold and dandruff was low, and storage stability was not good.

【0040】次に、実施例6〜実施例9及び比較例6〜
比較例9について、使用時の不快感の有無を調査した。
女性パネラー20名を1群とし、各群に実施例及び比較
例のそれぞれをブラインドにて使用させ、皮膚に塗布し
た後30秒から1分後の間に感じる刺すような痛み,ヒ
リヒリ感,チクチク感といった不快感について評価させ
た。評価結果は、「非常に強く感じる;5点」,「やや
強く感じる;4点」,「明確に感じる;3点」,「少し
感じる;2点」,「微妙に感じる;1点」,「感じな
い;0点」として点数化して表し、20名の平均値を表
7に示した。
Next, Examples 6 to 9 and Comparative Examples 6 to
In Comparative Example 9, the presence or absence of discomfort during use was investigated.
Each group consisted of 20 female panelists, and each group was allowed to use each of the examples and comparative examples with a blind. From 30 seconds to 1 minute after application to the skin, stinging pain, burning, and tingling Discomfort such as feeling was evaluated. The evaluation results are "very strong; 5 points", "somewhat strong; 4 points", "clearly; 3 points", "a little; 2 points", "subtle; 1 point", " Not felt; 0 point "is shown as a score. Table 7 shows the average value of 20 persons.

【0041】[0041]

【表7】 表7において、本発明の実施例使用群では、いずれもそ
れぞれ対応する比較例使用群に比べて、皮膚に塗布した
際に感じる不快感は著しく低減されており、使用時の感
触に優れることが示されている。
[Table 7] In Table 7, in the group using the examples of the present invention, the discomfort felt when applied to the skin was significantly reduced as compared with the corresponding groups using the corresponding comparative examples, and the feel during use was excellent. It is shown.

【0042】続いて、界面活性剤含量の高い実施例10
〜実施例12及び比較例10〜比較例12について、皮
膚刺激性の評価を行った。各実施例及び比較例の1.0
重量%水溶液を試料とし、男性パネラー30名を用い
て、背部皮膚にて48時間の閉塞貼付試験を行い、表8
に示す判定基準により皮膚刺激指数を求め、30名の平
均値を求めた。結果は表9に示した。
Subsequently, Example 10 having a high surfactant content was used.
About Example 12 and Comparative Examples 10 to 12, skin irritation was evaluated. 1.0 of each Example and Comparative Example
A 48% by weight aqueous solution was used as a sample, and a 48-hour obstruction sticking test was performed on the back skin using 30 male panelists.
The skin irritation index was determined according to the criterion shown in Table 2, and the average value of 30 persons was determined. The results are shown in Table 9.

【表8】 [Table 8]

【0043】[0043]

【表9】 表9において、比較例についてはいずれも高い皮膚刺激
指数が認められ、特に比較例12については、著しい紅
斑及び浮腫の発生を認めていた。これに対し、本発明の
実施例では、顕著な皮膚刺激指数の低減が見られた。
[Table 9] In Table 9, high skin irritation index was observed in all Comparative Examples, and particularly, in Comparative Example 12, significant erythema and edema were observed. In contrast, in the examples of the present invention, a remarkable reduction in the skin irritation index was observed.

【0044】[0044]

【発明の効果】以上詳述したように、本発明により、皮
膚の老化症状や炎症の防止,改善効果、皮膚の清浄化及
び美白効果に優れ、且つ良好な抗菌活性を有し、安定性
及び安全性に優れる皮膚外用剤を得ることができた。
As described above in detail, according to the present invention, it is excellent in the effect of preventing and improving the aging symptoms and inflammation of the skin, in the effect of cleansing and whitening the skin, and has good antibacterial activity, stability and An external preparation for skin excellent in safety was obtained.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 A61K 7/00 A61K 7/00 W 7/48 7/48 ──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 6 Identification number Office reference number FI Technical display location A61K 7/00 A61K 7/00 W 7/48 7/48

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】 生薬「山慈姑」の抽出物を含有して成
る、皮膚外用剤。
1. An external preparation for skin comprising an extract of a crude drug "Yamajiku".
【請求項2】 サイハイラン(Cremastra appendiculat
a Makino)の抽出物、ドクサンラン(Pleione bulbocod
ioides)の抽出物、及びアマナ(Tulipa edulis Bake
r)の抽出物より選ばれる1種又は2種以上を含有する
ことを特徴とする、皮膚外用剤。
2. Saisairan ( Cremastra appendiculat)
a Makino) extract, Pleione bulbocod
ioides ) extract and amana ( Tulipa edulis Bake)
An external preparation for skin, comprising one or more selected from the extracts of r).
【請求項3】 皮膚外用剤が、化粧料であることを特徴
とする、請求項1又は請求項2に記載の皮膚外用剤。
3. The external preparation for skin according to claim 1, wherein the external preparation for skin is a cosmetic.
JP18132296A 1996-06-20 1996-06-20 Topical skin preparation Expired - Fee Related JP3805022B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP18132296A JP3805022B2 (en) 1996-06-20 1996-06-20 Topical skin preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18132296A JP3805022B2 (en) 1996-06-20 1996-06-20 Topical skin preparation

Publications (2)

Publication Number Publication Date
JPH107582A true JPH107582A (en) 1998-01-13
JP3805022B2 JP3805022B2 (en) 2006-08-02

Family

ID=16098666

Family Applications (1)

Application Number Title Priority Date Filing Date
JP18132296A Expired - Fee Related JP3805022B2 (en) 1996-06-20 1996-06-20 Topical skin preparation

Country Status (1)

Country Link
JP (1) JP3805022B2 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004016236A1 (en) * 2002-08-14 2004-02-26 Fancl Corporation Cosmetics
JP2005179217A (en) * 2003-12-17 2005-07-07 Nomura:Kk Bleaching agent
JP2005179218A (en) * 2003-12-17 2005-07-07 Nomura:Kk Skin care preparation for external use containing mercaptoindole derivative
FR2871058A1 (en) * 2004-06-03 2005-12-09 Gunzburg Jean De ASSOCIATION BASED ON PLANT EXTRACTS AND TOPICAL COMPOSITION CONTAINING THE SAME
US20110207807A1 (en) * 2008-09-02 2011-08-25 Catholic University Industry Academy Cooperation Foundation New use for homoisoflavone or a salt thereof

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3068893B1 (en) * 2017-07-17 2021-02-19 Caster TULIP EXTRACT

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02279618A (en) * 1989-04-20 1990-11-15 Ichimaru Pharcos Co Ltd Cosmetic containing extract of plant of family orchidaceae
JPH05294813A (en) * 1992-02-17 1993-11-09 Manabu Nomura Hair producing and hair growing agent
JPH06172134A (en) * 1992-12-03 1994-06-21 Kazusaku Saigou Hair tonic also useful for preventing white hair comprising kadsura japonica dunal as main component

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02279618A (en) * 1989-04-20 1990-11-15 Ichimaru Pharcos Co Ltd Cosmetic containing extract of plant of family orchidaceae
JPH05294813A (en) * 1992-02-17 1993-11-09 Manabu Nomura Hair producing and hair growing agent
JPH06172134A (en) * 1992-12-03 1994-06-21 Kazusaku Saigou Hair tonic also useful for preventing white hair comprising kadsura japonica dunal as main component

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
奥田拓男編集, 天然薬物事典, JPN4006004761, 1986, pages 16 - 168, ISSN: 0000721611 *
奥田拓男編集, 天然薬物事典, JPNX006018803, 1986, pages 16 - 168, ISSN: 0000733178 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004016236A1 (en) * 2002-08-14 2004-02-26 Fancl Corporation Cosmetics
JP2005179217A (en) * 2003-12-17 2005-07-07 Nomura:Kk Bleaching agent
JP2005179218A (en) * 2003-12-17 2005-07-07 Nomura:Kk Skin care preparation for external use containing mercaptoindole derivative
FR2871058A1 (en) * 2004-06-03 2005-12-09 Gunzburg Jean De ASSOCIATION BASED ON PLANT EXTRACTS AND TOPICAL COMPOSITION CONTAINING THE SAME
WO2006000689A1 (en) * 2004-06-03 2006-01-05 De Gunzburg, Terry Association of vegetal extracts based on gooseberries, black orchids and black tulips and topical composition comprising the association of said vegetal extracts
US20110207807A1 (en) * 2008-09-02 2011-08-25 Catholic University Industry Academy Cooperation Foundation New use for homoisoflavone or a salt thereof

Also Published As

Publication number Publication date
JP3805022B2 (en) 2006-08-02

Similar Documents

Publication Publication Date Title
JPH1045615A (en) Plant extract-containing fibroblast growth promoter
KR102142311B1 (en) Skin external composition comprising tangeretin
JPH05186324A (en) Beautifying cosmetic
JP2005187474A (en) Improved scented cosmetic
JPH11263720A (en) Antiaging agent
JP2001335499A (en) Cosmetic composition
EP2100593B1 (en) Ternary mixtures with increased collagen synthesis
JPH10203955A (en) Antimicrobial low-irritating cosmetic
AU2002256933A1 (en) A pharmaceutical composition for the treatment of seborrhea containing 4-hydroxy-5-methoxy-4-[2-methyl-3(3-methyl-2-butenyl)-2-oxiranyl]-1-oxaspiro[2,5]octan-6-one
JP3667027B2 (en) Topical skin preparation
JP3805022B2 (en) Topical skin preparation
JP2001114636A (en) Hyaluronic acid production and catalase production promoting agent, fibroblast activating agent and skin lotion
JP4056570B2 (en) Lemongrass extract-containing cosmetic
JPH1025220A (en) Preparation for external use for skin
JPH03112912A (en) Cosmetic composition
JP2002370962A (en) Bleaching preparation and cosmetic for preventing and improving aging of skin
JP3083105B2 (en) Cosmetics
KR20040056079A (en) Cosmetic composition for preventing and therapeutic for a pimple
JP2002114629A (en) Cosmetic
JP3611553B2 (en) Skin preparation
JP2003238429A (en) Fibroblast cell-activating agent and skin external agent containing the same
JPH11302147A (en) Cosmetic
JP4011945B2 (en) Topical skin preparation
JP5144048B2 (en) Radical scavenger, antioxidant skin external preparation, and radical scavenging method
JPH10194917A (en) Antimicrobial and low-irritating cosmetic

Legal Events

Date Code Title Description
A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20060308

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20060314

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060328

RD05 Notification of revocation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7425

Effective date: 20060328

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20060508

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20060509

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100519

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100519

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110519

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120519

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130519

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130519

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140519

Year of fee payment: 8

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees